PX3 DIAGNOSTICS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: OV
Ove Vincent Solesvik1954
Years since formation: 13 years; since Jun 20, 2012
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 30,000; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2023: 280,000; NOK
Annual total result 2023: 169,815; NOK
Total equity 2023: -11,889; NOK

Last update: Sep 7, 2024

Management

Board

Name	Role	Shares
OV Ove Vincent Solesvik 1954	Contact Person, Chairman	-
BO Brit Oppedal 1954	Alternate Member	-

Others

Name	Role	Shares
A AIDER AS	Accountant	-

Last update: Aug 27, 2024

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
OV Ove Vincent Solesvik 1954	Ordinary shares	30,000	100 %

Shares owned by the PX3 DIAGNOSTICS AS

Name	Share class	Total number of shares	Share
G GREINDX AS	Ordinary shares	37,553	31.39 %
N NAALOS HOLDING AS	Ordinary shares	6,585	21.95 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	280,000	265,000	70,000
Annual Total Result	169,815	110,016	-34,105
Total assets	261,807	236,801	217,261
Total liabilities	273,696	418,505	508,981
Total equity	-11,889	-181,704	-291,720

P&L

Year	2023	2022	2021
Total operating income	280,000	265,000	70,000
Total operating costs	124,444	154,984	104,105
Operating result	155,556	110,016	-34,105
Financial income/costs	14,259	0	0
Profit before tax	169,815	110,016	-34,105
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	169,815	110,016	-34,105

Balance overview

Year	2023	2022	2021
Total fixed assets	31,955	79,455	173,470
Total current assets	229,852	157,346	43,791
Total assets	261,807	236,801	217,261
Short term debt	31,359	0	508,981
Long term debt	242,337	418,505	0
Total liabilities	273,696	418,505	508,981
Contributed capital	30,000	30,000	30,000
Retained earnings	-41,889	-211,704	-321,720
Total equity	-11,889	-181,704	-291,720
Total equity and liabilities	261,807	236,801	217,261

PX3 DIAGNOSTICS AS998 461 553